Navigating the New Legal Landscape: The Impact of Loper Bright on Federal Marijuana Rescheduling
By Jean Smith-Gonnell and Dascher Pasco
The federal rescheduling of marijuana has been a topic of conversation within the marijuana industry since President Biden’s statement requesting that the secretary of health and human services (HHS) and the attorney general (AG) “initiate the administrative process to review expeditiously how marijuana is scheduled under federal law.”[1] However, the Supreme Court’s recent decision overturning the Chevron doctrine adds an additional layer to an already complicated process. While the exact impact of Loper Bright Enterprises v. Raimondo[2] on the cannabis industry remains to be seen, this article explores the way in which it may impact the pending rescheduling.
Rescheduling and Recreational Marijuana: Possible Step Toward National Legalization?
By Jean Smith-Gonnell and Michael Lafleur
Published in Reuters on July 2, 2024.
On May 16, 2024, the Department of Justice (DOJ) issued its Notice of Proposed Rulemaking (NPRM) related to the transfer of marijuana from schedule I of the Controlled Substances Act (CSA) to schedule III, consistent with the recommendation provided by the Department of Health and Human Services (HHS) in August 2023. The CSA requires that rescheduling must be accomplished through a formal rulemaking process and public comment starting 60 days from the date of publication in the Federal Register.
The Path and Politics of Marijuana Legislation: State-by-State Progress and Future Directions
By Jean Smith-Gonnell and Gina Hitchman*
I. Today’s Marijuana Landscape
Despite marijuana’s continued federal classification as a Schedule I controlled substance,[1] 26 states and the District of Columbia have passed laws at least partially decriminalizing marijuana possession and recreational use.[2] A majority of Americans now live in states where marijuana is legal for recreational use,[3] and nearly three-quarters of Americans live in states that have legalized marijuana for either recreational or medical sales and use.[4] Currently, 14 states have only legalized medical use,[5] while 24 states and the District of Columbia have implemented regulatory schemes for both medical and recreational use.[6] Of the remaining 12 states where marijuana is still illegal, possession is decriminalized in two states.[7] The map below illustrates these categories.[8]
